UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.949

Sortiert nach

Low‐Dose Chemotherapy and Rituximab for Posttransplant Lymphoproliferative Disease (PTLD): A Children's Oncology Group Report

American journal of transplantation, 2012-11, Vol.12 (11), p.3069-3075

2012

Link zum Volltext

Verfügbarkeit prüfen

Protein phosphatase 1 regulatory subunit 1A in ewing sarcoma tumorigenesis and metastasis

Oncogene, 2018-02, Vol.37 (6), p.798-809

2018

Link zum Volltext

Verfügbarkeit prüfen

Rescuing the neonatal brain from hypoxic injury with autologous cord blood

Bone marrow transplantation (Basingstoke), 2013-07, Vol.48 (7), p.890-900

2013

Link zum Volltext

Verfügbarkeit prüfen

Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease

Bone marrow transplantation (Basingstoke), 2014-07, Vol.49 (7), p.913-920

2014

Link zum Volltext

Verfügbarkeit prüfen

Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS

Bone marrow transplantation (Basingstoke), 2012-02, Vol.47 (2), p.203-211

2012

Link zum Volltext

Verfügbarkeit prüfen

Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children's Oncology Group report

Leukemia, 2013-05, Vol.27 (5), p.1174-1177

2013

Link zum Volltext

Verfügbarkeit prüfen

Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB LMB 96 international study

Leukemia, 2009-02, Vol.23 (2), p.323-331

2009

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE

Neurology, 2006-10, Vol.67 (8), p.1458

2006

Link zum Volltext

Verfügbarkeit prüfen

Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant

Bone marrow transplantation (Basingstoke), 2004-10, Vol.34 (8), p.721-727

2004

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic cellular and autologous stem cell therapy for sickle cell disease: 'whom, when and how'

Bone marrow transplantation (Basingstoke), 2012-12, Vol.47 (12), p.1489-1498

2012

Link zum Volltext

Verfügbarkeit prüfen

A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescents

Bone marrow transplantation (Basingstoke), 2011-06, Vol.46 (6), p.790-799

2011

Link zum Volltext

Verfügbarkeit prüfen

Pediatric allo-SCT for malignant and non-malignant diseases: impact on health-related quality of life outcomes

Bone marrow transplantation (Basingstoke), 2013-06, Vol.48 (6), p.787-793

2013

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic cell transplantation for Chediak-Higashi syndrome

Bone marrow transplantation (Basingstoke), 2007-04, Vol.39 (7), p.411-415

2007

Link zum Volltext

Verfügbarkeit prüfen

New frontiers in pediatric Allo-SCT

Bone marrow transplantation (Basingstoke), 2014-09, Vol.49 (9), p.1139-1145

2014

Link zum Volltext

Verfügbarkeit prüfen

Pericardial effusion post-SCT in pediatric recipients with signs and or symptoms of cardiac disease

Bone marrow transplantation (Basingstoke), 2011-04, Vol.46 (4), p.529-538

2011

Link zum Volltext

Verfügbarkeit prüfen

A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients

Bone marrow transplantation (Basingstoke), 2004-03, Vol.33 (6), p.613-622

2004

Link zum Volltext

Verfügbarkeit prüfen

Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases

Bone marrow transplantation (Basingstoke), 2007-10, Vol.40 (7), p.621-631

2007

Link zum Volltext

Verfügbarkeit prüfen

Long-term remission in a child with refractory EBV hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV -related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy

Bone marrow transplantation (Basingstoke), 2011-05, Vol.46 (5), p.759-761

2011

Link zum Volltext

Verfügbarkeit prüfen

The pharmacokinetics and safety of twice daily i.v. BU during conditioning in pediatric allo-SCT recipients

Bone marrow transplantation (Basingstoke), 2013-01, Vol.48 (1), p.19-25

2013

Link zum Volltext

Verfügbarkeit prüfen

Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms’ tumor: a Children’s Cancer Group report

Annals of oncology, 2002-03, Vol.13 (3), p.460-469

2002

Link zum Volltext

Verfügbarkeit prüfen

Elitek™-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002

Leukemia, 2003-03, Vol.17 (3), p.499-514

2003

Link zum Volltext

Verfügbarkeit prüfen

Successful Transplantation of HLA-Matched and HLA-Mismatched Umbilical Cord Blood From Unrelated Donors: Analysis of Engraftment and Acute Graft-Versus-Host Disease

Blood, 1996-08, Vol.88 (3), p.795-802

1996

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of unrelated cord blood transplantation in pediatric recipients

Bone marrow transplantation (Basingstoke), 2004-07, Vol.34 (2), p.129-136

2004

Link zum Volltext

Verfügbarkeit prüfen

Cellular engineering and therapy in combination with cord blood allografting in pediatric recipients

Bone marrow transplantation (Basingstoke), 2016-01, Vol.51 (1), p.27-33

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.949

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.087)
Mit Volltextzugriff
(2.509)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.607)
Life Sciences & Biomedicine
(1.250)
Humans
(556)
Biological And Medical Sciences
(493)
Animals
(378)
Female
(362)
Male
(348)
Fundamental And Applied Biological Sciences. Psychology
(308)
Physical Sciences
(284)
Hematology
(205)
Adult
(204)
Medical Sciences
(202)
Technology
(194)
Child
(181)
Adolescent
(171)
Physics
(144)
Child, Preschool
(138)
Oncology
(136)
Immunology
(130)
Agriculture
(126)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Low‐Dose Chemotherapy and Rituximab for Posttransplant Lymphoproliferative Disease (PTLD): A Children's Oncology Group Report

Protein phosphatase 1 regulatory subunit 1A in ewing sarcoma tumorigenesis and metastasis

Rescuing the neonatal brain from hypoxic injury with autologous cord blood

Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease

Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS

Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children's Oncology Group report

Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB LMB 96 international study

Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE

Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant

Allogeneic cellular and autologous stem cell therapy for sickle cell disease: 'whom, when and how'

A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescents

Pediatric allo-SCT for malignant and non-malignant diseases: impact on health-related quality of life outcomes

Hematopoietic cell transplantation for Chediak-Higashi syndrome

New frontiers in pediatric Allo-SCT

Pericardial effusion post-SCT in pediatric recipients with signs and or symptoms of cardiac disease

A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients

Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases

Long-term remission in a child with refractory EBV hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV -related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy

The pharmacokinetics and safety of twice daily i.v. BU during conditioning in pediatric allo-SCT recipients

Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms’ tumor: a Children’s Cancer Group report

Elitek™-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002

Successful Transplantation of HLA-Matched and HLA-Mismatched Umbilical Cord Blood From Unrelated Donors: Analysis of Engraftment and Acute Graft-Versus-Host Disease

Outcomes of unrelated cord blood transplantation in pediatric recipients

Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma

Cellular engineering and therapy in combination with cord blood allografting in pediatric recipients

Suchergebnisse filtern